Welcome to DukeHealth.org.
Skip over navigation
Skip over navigation
- Home
- Patient and Visitor Info
- Physicians
- Services
- Clinical Trials
- Event Calendar
- Locations
- Health Library
- About Duke Medicine
Quick Links
Home
>
Clinical Trials
>
A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication (IC)
A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cells for the Treatment of Subjects with Intermittent Claudication (IC)
Share
Intramuscular injection of placental (PLX-PAD) cells versus placebo for the treatment of patients with peripheral artery disease and intermittent claudication. Patients must have "limited options" for revascularization (either with surgery or percutaneous options).
Age 40-80 years. Duration: 6 months. Number of visits: 5.
For more information, contact Schuyler Jones, MD at 919-681-3945.
(REF# Pro00038962)
